Procter & Gamble Q2 Earnings: What to Expect

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Procter & Gamble Q2 Earnings: What to Expect

© courtesy Procter & Gamble Co.

Procter & Gamble Co. (NYSE: PG) is scheduled to release its fiscal second-quarter financial results before the markets open on Tuesday. The consensus estimates from Thomson Reuters call for $0.98 in earnings per share (EPS) on $16.95 billion in revenues. In the same period of the previous year, the company posted EPS of $0.95 and revenue of $20.16 billion.

The stock lost about 10% in 2015, and the company’s restructuring hasn’t seemed to help. Procter & Gamble still wants to get rid of more product groups to focus on core and growth markets. Now it yields around 3.3%, but its valuation at roughly 18 times earnings just doesn’t feel cheap yet. Maybe it can have a better 2016, as analysts are looking for a 5% price gain, before taking the yield into consideration.

This is a solid consumer staples stock, especially for conservative investors to consider. It sells lots of run-of-the-mill household items that are essential for everyday life, but it is not content to stand pat on its laurels.

The company actually is innovative in its product development process and uses that to help ensure future growth and cash flow. This should provide investors years of steady growth and dividends. While currency headwinds have weighed on recent earnings and projections, the dollar may be topping out would bode very well for the future.
[recirclink id=310519]
A few analysts recently weighed in on Procter & Gamble prior to the release of its earnings report:

  • Stifel upgraded it to a Buy rating from a Hold with an $85 price target.
  • Atlantic Securities initiated coverage with a Neutral rating and an $84 price target.
  • Canaccord Genuity reiterated a Hold rating with an $82 price target.

So far in 2016, this company has outperformed the broad markets, with the stock down only 1.7%. Over the past 52 weeks, the stock is down over 12%.

Shares of Procter & Gamble were trading down 0.4% at $77.08 on Monday, with a consensus analyst price target of $83.11 and a 52-week trading range of $65.02 to $89.95.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618